These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 21267013)

  • 21. T(reg) stability: to be or not to be.
    Overacre AE; Vignali DA
    Curr Opin Immunol; 2016 Apr; 39():39-43. PubMed ID: 26774863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo.
    Darrasse-Jèze G; Deroubaix S; Mouquet H; Victora GD; Eisenreich T; Yao KH; Masilamani RF; Dustin ML; Rudensky A; Liu K; Nussenzweig MC
    J Exp Med; 2009 Aug; 206(9):1853-62. PubMed ID: 19667061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasticity of T(reg) cells: is reprogramming of T(reg) cells possible in the presence of FOXP3?
    Beyer M; Schultze JL
    Int Immunopharmacol; 2011 May; 11(5):555-60. PubMed ID: 21115121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression.
    Peterson RA
    Toxicol Pathol; 2012; 40(2):186-204. PubMed ID: 22222887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma.
    Klein S; Kretz CC; Ruland V; Stumpf C; Haust M; Hartschuh W; Hartmann M; Enk A; Suri-Payer E; Oberle N; Krammer PH; Kuhn A
    Ann Rheum Dis; 2011 Aug; 70(8):1475-81. PubMed ID: 21097800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR7 with S1P1 signaling through AP-1 for migration of Foxp3+ regulatory T-cells controls autoimmune exocrinopathy.
    Ishimaru N; Yamada A; Nitta T; Arakaki R; Lipp M; Takahama Y; Hayashi Y
    Am J Pathol; 2012 Jan; 180(1):199-208. PubMed ID: 22067914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells.
    Lim HW; Broxmeyer HE; Kim CH
    J Immunol; 2006 Jul; 177(2):840-51. PubMed ID: 16818738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes.
    Feuerer M; Hill JA; Mathis D; Benoist C
    Nat Immunol; 2009 Jul; 10(7):689-95. PubMed ID: 19536194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional dynamics of Foxp3⁺ regulatory T cells in mice and humans.
    Bin Dhuban K; Kornete M; S Mason E; Piccirillo CA
    Immunol Rev; 2014 May; 259(1):140-58. PubMed ID: 24712464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of Regulatory T Cell Migration, Function, and Homeostasis.
    Campbell DJ
    J Immunol; 2015 Sep; 195(6):2507-13. PubMed ID: 26342103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells.
    Bayer AL; Yu A; Malek TR
    J Immunol; 2007 Apr; 178(7):4062-71. PubMed ID: 17371960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3.
    Williams LM; Rudensky AY
    Nat Immunol; 2007 Mar; 8(3):277-84. PubMed ID: 17220892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Foxp3-deficient regulatory T cells do not revert into conventional effector CD4+ T cells but constitute a unique cell subset.
    Kuczma M; Podolsky R; Garge N; Daniely D; Pacholczyk R; Ignatowicz L; Kraj P
    J Immunol; 2009 Sep; 183(6):3731-41. PubMed ID: 19710455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells.
    Klunker S; Chong MM; Mantel PY; Palomares O; Bassin C; Ziegler M; Rückert B; Meiler F; Akdis M; Littman DR; Akdis CA
    J Exp Med; 2009 Nov; 206(12):2701-15. PubMed ID: 19917773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Ets-1 transcription factor controls the development and function of natural regulatory T cells.
    Mouly E; Chemin K; Nguyen HV; Chopin M; Mesnard L; Leite-de-Moraes M; Burlen-defranoux O; Bandeira A; Bories JC
    J Exp Med; 2010 Sep; 207(10):2113-25. PubMed ID: 20855499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Point mutants of forkhead box P3 that cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked have diverse abilities to reprogram T cells into regulatory T cells.
    McMurchy AN; Gillies J; Allan SE; Passerini L; Gambineri E; Roncarolo MG; Bacchetta R; Levings MK
    J Allergy Clin Immunol; 2010 Dec; 126(6):1242-51. PubMed ID: 21036387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profile.
    De Somer L; Fevery S; Bullens DM; Rutgeerts O; Lenaerts C; Mathieu C; Boon L; Kasran A; Waer M; Billiau AD
    Immunol Lett; 2010 Sep; 133(1):49-53. PubMed ID: 20600326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory T cells in human autoimmune diseases.
    Torgerson TR
    Springer Semin Immunopathol; 2006 Aug; 28(1):63-76. PubMed ID: 16902772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trafficking of FoxP3+ regulatory T cells: myths and facts.
    Kim CH
    Arch Immunol Ther Exp (Warsz); 2007; 55(3):151-9. PubMed ID: 17557143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.
    Kim JM; Rasmussen JP; Rudensky AY
    Nat Immunol; 2007 Feb; 8(2):191-7. PubMed ID: 17136045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.